Steatohepatitis (NASH and ASH)
U. Leuschner, O.F.W. James, H. Dancygier
Springer Science & Business Media, May 31, 2001 - Medical - 380 pages
This book is the proceedings of the Falk Symposium No. 121 on 'Steatohepatitis (NASH and ASH)', held in Den Haag, The Netherlands, on October 14-15, 2000. The histological features of what we now call non-alcoholic steatohepatitis were described as early as 1962 by the Honorary President of the Symposium, Professor Herbert Thaler, from Vienna. Others followed, and in 1980 Jürgen Ludwig, one of the speakers of this symposium, introduced the name `non-alcoholic steatohepatitis' or NASH. In a Consensus Symposium organized by the National Institute of Health (NIH) in Washington, USA, in December 1998, NASH was recognized as one of the most common liver diseases in Western countries when viral hepatitis and heavy alcohol consumption were excluded.
ASH, or alcoholic steatohepatitis, is more common than NASH, since alcohol is omnipresent in Western as well as Eastern cultures. Histologically NASH and ASH are similar or even identical. Morphological findings range from fatty degeneration to inflammation and fibrosis, and may end up in liver cirrhosis. In spite of the well-defined morphological features, our knowledge of epidemiology, aetiology, and pathogenesis is full of gaps, especially for NASH. Therefore, it is the purpose of this book to show the state of the art, to discuss recent scientific data, and to suggest possible treatment strategies, hoping to stimulate clinicians as well as scientists.
What people are saying - Write a review
We haven't found any reviews in the usual places.
abnormalities activity alcohol abuse Alcohol Clin Exp alcohol-induced liver alcoholic hepatitis alcoholic liver disease alcoholic steatohepatitis apoptosis associated Biochem Biol cause chronic ethanol chronic hepatitis cirrhosis Clin Exp Res clinical cryptogenic cirrhosis cytochrome cytokines decreased diabetes diagnosis diet drugs effect endotoxin enzyme ethanol ethanol-induced EtOH fatty acids fatty liver fatty liver disease Fromenty function Gastroenterol Gastroenterology gene glucocorticosteroids glutathione hepatic iron hepatic steatosis hepatocytes Hepatol Hepatology histological impaired increased induced inflammation insulin resistance Kupffer cells leptin lesions levels Lieber lipid peroxidation liver biopsy liver injury Mallory bodies membrane metabolism mice microsomal mitochondrial mortality mtDNA mutations NAFLD necrosis non-alcoholic steatohepatitis normal nutrition obesity oxidative stress pathogenesis patients with alcoholic patients with NASH Pessayre placebo plasma protein rats respiratory chain risk factors role ROS formation serum severe alcoholic hepatitis significant syndrome therapy tion tissue TNF-o toxicity transferrin treatment trials triglycerides vitamin